This setting mimics the complex and functional environment of metastases including tumor stroma and tumor microenvironment and serves as ideal model for evaluation of the feasibility of the NIS gene therapy concept after EGFR-targeted nonviral gene transfer. The gene discussed is EGFR; the disease is neoplasm.